1.87% 0.59

Soleno Therapeutics Inc (SLNO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Soleno Therapeutics Inc-Aktie (SLNO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	32.66	-	-	-	-
Cost Of Revenue	0.696	-	-	-	-
Gross Profit	31.96	-	-	-	-
Operating Expenses	14.34% 39.18	45.74	59.12	80.21	24.87
Benefits Costs and Expenses	6.61% 39.18	41.96	-	-	-
Costs And Expenses	14.34% 39.18	45.74	-	-	-
Depreciation and Amortization	0.40% 0.502	0.504	0.503	0.50	0.494
Operating Income/Loss	85.74% -6.525	-45.74	-59.12	-80.21	-24.87
Nonoperating Income/Loss	7.77% 1.817	1.97	3.134	3.596	3.014
Income/Loss From Continuing Operations Before Tax	85.09% -6.525	-43.77	-55.98	-76.62	-21.85
Income/Loss From Continuing Operations After Tax	89.24% -4.708	-43.77	-55.98	-76.62	-21.85
Net Income/Loss	89.24% -4.708	-43.77	-55.98	-76.62	-21.85
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	9.32% 50.48	46.18	1.2588	41.88	38.63
Diluted Average Shares	9.32% 50.48	46.18	1.2588	41.88	38.63
Basic Earnings Per Share	90.53% -0.09	-0.95	-1.30	-1.83	-0.57
Diluted Earnings Per Share	90.53% -0.09	-0.95	-1.30	-1.83	-0.57
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.41

0.51%

GMAB

$28.83

0.42%

INCY

$100.47

1.20%

BNTX

$103.85

0.08%

ONC

$310.01

0.52%

INSM

$184.61

0.50%